Cargando…
Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer
Objective: Long-term survivors (LS) of non-small cell lung cancer (NSCLC) without driver alterations, displaying an overall survival (OS) of more than 3 years, comprise around 10% of cases in several series treated with chemotherapy. There are classical prognosis factors for these cases [stage, East...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309469/ https://www.ncbi.nlm.nih.gov/pubmed/32587780 http://dx.doi.org/10.20892/j.issn.2095-3941.2019.0363 |